Transcatheter embolization of bronchial arteirias in the treatment of hemoptysis (CROSBI ID 153634)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Podaci o odgovornosti
Vidjak, Vinko ; Novačić, Karlo ; Hebrang, Andrija ; Mažuranić, Ivica ; Samaržija, Miroslav ; Ljubić, Spomenka ; Breitenfeld, Tomislav ; Klasić, Branimir ;
engleski
Transcatheter embolization of bronchial arteirias in the treatment of hemoptysis
Background. Massive hemoptysis is a clinical state characterized by the expectoration of blood at a rate of 300-600 mL/24 h, thus causing life-threatening asphyxia. The aim of our study is to review use of transcatheter bronchial artery embolization (BAE) in the treatment of massive hemoptysis. Materials and methods. Series of 11 patients with clinical picture of massive hemoptysis was referred to our hospital for digital subtraction angiography and BAE within a 33 months period. Results. Bronchiectasis was the most common cause of bleeding (45.4%), while hypervascularization and pathologic parenchymal contrast imbibition were the most frequent angiographic indicators of bleeding (100%), followed by tortuous and hypertrophic arteries (72.7%). Primary BAE proved successful in 81.9% and secondary BAE performed within 24 months in 33.3% of patients, whereas tertiary (operative) treatment was required in 22.2% of patients. In 44.4% of patients, BAE was associated with only mild discomforts. Conclusions. BAE is a reliable and minimally invasive method in the management of massive hemoptysis.
BAE; hemoptysis
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
Povezanost rada
nije evidentirano